Development and Evaluation of a Modified Fixed-Dose Combination Antihypertensive Tablet Containing S-Amlodipine Besylate: A Bioequivalence and Stability Study

<b>Background</b>/<b>Objectives</b>: Fixed-dose combination (FDC) antihypertensive medications containing olmesartan medoxomil, amlodipine besylate, and hydrochlorothiazide are widely used for the treatment of essential hypertension. Although effective, the use of racemic aml...

Full description

Bibliographic Details
Published in:	Pharmaceutics
Main Authors:	Hyeon Woo Moon, Jin-Hyuk Jeong, Chun-Woong Park
Format:	Article
Language:	English
Published:	MDPI AG 2025-09-01
Subjects:	S-amlodipine besylate olmesartan medoxomil hydrochlorothiazide fixed-dose combination bilayer tablet stability
Online Access:	https://www.mdpi.com/1999-4923/17/9/1235

Similar Items

Simultaneous quantitative analysis of olmesartan, amlodipine and hydrochlorothiazide in their combined dosage form utilizing classical and alternating least squares based chemometric methods
by: Darwish Hany W., et al.
Published: (2016-03-01)

Efficacy and safety of olmesartan medoxomil‐amlodipine besylate tablet in Chinese patients with essential hypertension: A prospective, single‐arm, multi‐center, real‐world study
by: Zhaoqiang Cui, et al.
Published: (2024-01-01)

EVALUATION OF ANTIHYPERTENSIVE THERAPY WITH THE COMBINATION OF OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE
by: Steven G. Chrysant, et al.
Published: (2011-06-01)

Validated HPTLC methods for determination of some selected antihypertensive mixtures in their combined dosage forms
by: Rasha A. Shaalan, et al.
Published: (2014-12-01)

Method development for simultaneous estimation of Amlodipine Besylate and Perindopril Tertbutyl amine in fixed-dose
by: Muhammad Farooq Saleem Khan, et al.
Published: (2023-03-01)

Development of a Scalable Process of Film-Coated bi-Layer Tablet Containing Sustained-Release Metoprolol Succinate and Immediate-Release Amlodipine Besylate
by: Nguyen Thi Linh Tuyen, et al.
Published: (2021-10-01)

Inclusion complexes of amlodipine besylate and cyclodextrins
by: Kapor Agneš, et al.
Published: (2010-08-01)

Development of Colorimetric Method for the Quantitative Analysis of Amlodipine Besylate in Dosage form Using 4-Dimethyleaminobenzaldehyde as Derivatizing Reagent
by: Abdul Ghani Memon, et al.
Published: (2020-06-01)

Efficacy and safety of fixed-dose combination therapy with olmesartan medoxomil and rosuvastatin in Korean patients with mild to moderate hypertension and dyslipidemia: an 8-week, multicenter, randomized, double-blind, factorial-design study (OLSTA-D RCT: OLmesartan rosuvaSTAtin from Daewoong)
by: Park JS, et al.
Published: (2016-08-01)

Amlodipine besylate photocatalytic degradation using titanium dioxide: Adsorption isotherms and kinetics
by: Diala Koumeir, et al.
Published: (2025-07-01)

Interaction and Compatibility Studies in the Development of Olmesartan Medoxomil and Hydrochlorothiazide Formulations under a Real Manufacturing Process
by: Mac Arturo Murillo-Fernández, et al.
Published: (2022-02-01)

A New method for simultaneous qualitative and quantitative determination of amlodipine besylate and atorvastatin calcium in bulk and pharmaceutical formulations using transmission FT-IR spectroscopy
by: Sherwan Ibesh, et al.
Published: (2023-03-01)

TRIPLE ANTIHYPERTENSIVE THERAPY: FOCUS ON EFFICACY AND PROGNOSIS
by: O. D. Ostroumova, et al.
Published: (2018-07-01)

Simultaneous estimation of nebivolol hydrochloride and amlodipine besylate in human plasma employing an innovative HPLC chromatographic method
by: Kaveri T. Vaditake, et al.
Published: (2024-10-01)

A new RP–HPLC method for simultaneous quantification of perindopril erbumine, indapamide, and amlodipine besylate in bulk and pharmaceutical dosage form
by: Kirtan P. Patel, et al.
Published: (2020-11-01)

Does Price Really Matter for Generic Alternatives? Supervised learning Approaches in Deciding the Right Price for Acceptable Quality Attributes of Amlodipine Besylate among Generic Alternatives
by: Laltanpuii Chenkual, et al.
Published: (2024-04-01)

Real-world evidence on the strategy of olmesartan-based triple single-pill combination in Korean hypertensive patients: a prospective, multicenter, observational study (RESOLVE-PRO)
by: Il Suk Sohn, et al.
Published: (2021-11-01)

EFFICACY OF FIXED COMBINATION OF VALSARTAN, AMLODIPINE AND HYDROCHLOROTHIAZIDE IN COMPLEX THERAPY OF THE PATIENT OF VERY HIGH CARDIOVASCULAR RISK
by: I. M. Sokolov, et al.
Published: (2015-12-01)

Study of forced degradation of amlodipine besylate and bisoprolol fumarate by application of hydrophilic interaction liquid chromatography
by: Kasagić-Vujanović Irena, et al.
Published: (2014-01-01)

Pharmacokinetic and bioequivalence study of a telmisartan/S-amlodipine fixed-dose combination (CKD-828) formulation and coadministered telmisartan and S-amlodipine in healthy subjects
by: Kang WY, et al.
Published: (2018-03-01)

A new stability-indicating HPLC-UV method for determination of amlodipine besylate and its impurities in drug substance
by: Salika Jeelani, et al.
Published: (2023-09-01)

Application of an LC–MS/MS method for the analysis of amlodipine, valsartan and hydrochlorothiazide in polypill for a bioequivalence study
by: Jaivik V. Shah, et al.
Published: (2017-10-01)

Spectrophotometric method for the determination of amlodipine besylate in pure and dosage forms using 7,7,8,8-tetracyanoquinodimethane and tetracyanoethylene
by: Nina Alizadeh, et al.
Published: (2014-06-01)

Bioequivalence and Food Effect Assessment of Two Fixed‐Dose Combination Formulations of Telmisartan‐Hydrochlorothiazide Tablets in Chinese Healthy Subjects
by: Minwan Hu, et al.
Published: (2025-05-01)

Solubility and thermodynamic analysis of amlodipine besylate in mixtures of propylene glycol and 1-propanol from 293.2 to 323.2 K
by: Homa Rezaei, et al.
Published: (2025-06-01)

Development and Evaluation of Feline Tailored Amlodipine Besylate Mini-Tablets Using L-lysine as a Candidate Flavouring Agent
by: Chinedu S. Ekweremadu, et al.
Published: (2020-09-01)

Olmesartan vs ramipril in the treatment of hypertension and associated clinical conditions in the elderly: a reanalysis of two large double blind, randomized studies at the light of the most recent blood pressure targets recommended by guidelines
by: Omboni S, et al.
Published: (2015-10-01)

Study of the Acidic, Basic, and Thermal Degradation Kinetics of Three Antihypertensive Drugs—Individually and in Combination
by: Nebojša Mandić-Kovacević, et al.
Published: (2024-11-01)

Evaluation of stability and simultaneous determination of fimasartan and amlodipine by a HPLC method in combination tablets
by: Hyeon Woo Moon, et al.
Published: (2014-06-01)

Clinical Benefit of Fixed‐Dose Combination of Amlodipine and Potent Atorvastatin in Patients With Concomitant Hypertension and Hypercholesterolemia
by: Chia‐Pin Lin, et al.
Published: (2024-05-01)

Comparative pharmacokinetics of a fixed-dose combination vs concomitant administration of telmisartan and S-amlodipine in healthy adult volunteers
by: Oh M, et al.
Published: (2017-12-01)

Single-Pill, Triple Antihypertensive Therapy in Rural Sub-Saharan Africa: Preliminary Experience
by: Clara Stroppa, et al.
Published: (2024-02-01)

Enhancing Oral Absorption of an Ester Prodrug by Coating Drug Crystals with Binary Lipid Systems and Evaluating the Influence of Compositions
by: Xiaowei Dong, et al.
Published: (2025-09-01)

EFFECT OF ANGIOTENSIN RECEPTOR BLOCKADE ON ENDOTHELIAL FUNCTION: FOCUS ON OLMESARTAN MEDOXOMIL
by: C. Ferrario
Published: (2010-12-01)

Host–Guest Complexation of Olmesartan Medoxomil by Heptakis(2,6-di-O-methyl)-β-cyclodextrin: Compatibility Study with Excipients
by: Dana Emilia Man, et al.
Published: (2024-12-01)

Olmesartan medoxomil-loaded mixed micelles: Preparation, characterization and in-vitro evaluation
by: Mohamed A. El-Gendy, et al.
Published: (2017-12-01)

The effective doses of remimazolam besylate in the procedural sedation of endoscopic retrograde cholangiopancreatography
by: Dan‐Dan Tan, et al.
Published: (2023-09-01)

Utilization of Localized Surface Plasmon Resonance of Silver Nanoparticles for ‎the Spectrophotometric Estimation of Amlodipine and Hydrochlorothiazide
by: Rasul Jameel Ali, et al.
Published: (2024-11-01)

Effect of olmesartan and amlodipine on serum angiotensin-(1–7) levels and kidney and vascular function in patients with type 2 diabetes and hypertension
by: Kyuho Kim, et al.
Published: (2023-03-01)

Pharmacokinetics and Bioequivalence of Two Fixed-Dose Combination Tablets of Valsartan/Amlodipine (80/5 Mg) in Healthy Chinese Subjects
by: Tian M, et al.
Published: (2025-01-01)